David J. Izon

4.7k total citations
49 papers, 3.7k citations indexed

About

David J. Izon is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, David J. Izon has authored 49 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 20 papers in Molecular Biology and 8 papers in Hematology. Recurrent topics in David J. Izon's work include T-cell and B-cell Immunology (20 papers), Immune Cell Function and Interaction (18 papers) and Immunotherapy and Immune Responses (15 papers). David J. Izon is often cited by papers focused on T-cell and B-cell Immunology (20 papers), Immune Cell Function and Interaction (18 papers) and Immunotherapy and Immune Responses (15 papers). David J. Izon collaborates with scholars based in Australia, United States and Netherlands. David J. Izon's co-authors include David Allman, Warren S. Pear, Dale I. Godfrey, C L Tucek, Trevor J. Wilson, Jennifer A. Punt, Richard L. Boyd, Corey Largman, H. Jeffrey Lawrence and Joachim R. Göthert and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

David J. Izon

49 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Izon Australia	25	2.1k	1.5k	629	598	313	49	3.7k
N. Shaun B. Thomas United Kingdom	30	1.9k 0.9×	778 0.5×	449 0.7×	735 1.2×	307 1.0×	56	3.1k
Rebecca J. Chan United States	32	2.2k 1.1×	917 0.6×	580 0.9×	531 0.9×	219 0.7×	90	3.3k
Johan Lennartsson Sweden	31	1.8k 0.9×	880 0.6×	388 0.6×	715 1.2×	321 1.0×	76	3.5k
David G. Motto United States	31	1.4k 0.7×	2.1k 1.5×	992 1.6×	367 0.6×	176 0.6×	58	3.9k
Richard J. D’Andrea Australia	36	2.6k 1.3×	856 0.6×	674 1.1×	534 0.9×	270 0.9×	89	3.9k
Roland P. Piekorz Germany	33	1.6k 0.8×	1.1k 0.7×	337 0.5×	1.0k 1.7×	396 1.3×	75	3.4k
Elizabeth J. Quackenbush United States	25	2.1k 1.0×	1.4k 1.0×	387 0.6×	857 1.4×	115 0.4×	45	3.8k
Wentian Yang United States	30	2.2k 1.1×	1.4k 1.0×	234 0.4×	750 1.3×	241 0.8×	51	3.5k
C H Heldin Sweden	24	1.6k 0.8×	573 0.4×	289 0.5×	553 0.9×	294 0.9×	26	3.0k
Ari Elson Israel	32	3.0k 1.4×	1.0k 0.7×	335 0.5×	1.2k 2.1×	573 1.8×	73	3.8k

Countries citing papers authored by David J. Izon

Since Specialization

Citations

This map shows the geographic impact of David J. Izon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Izon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Izon more than expected).

Fields of papers citing papers by David J. Izon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Izon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Izon. The network helps show where David J. Izon may publish in the future.

Co-authorship network of co-authors of David J. Izon

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Izon. A scholar is included among the top collaborators of David J. Izon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Izon. David J. Izon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smeets, Monique, Meaghan Wall, Julie Quach, et al.. (2014). The Rothmund-Thomson syndrome helicase RECQL4 is essential for hematopoiesis. Journal of Clinical Investigation. 124(8). 3551–3565. 34 indexed citations

Glaser, Stefan, Erinna F. Lee, Philippe Bouillet, et al.. (2012). Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia. Genes & Development. 26(2). 120–125. 317 indexed citations

Singbrant, Sofie, Brian Liddicoat, David J. Izon, et al.. (2011). Erythropoietin couples erythropoiesis, B-lymphopoiesis, and bone homeostasis within the bone marrow microenvironment. Blood. 117(21). 5631–5642. 111 indexed citations

Smeets, Monique, et al.. (2007). An in vivo functional genetic screen for suppressors of the Rag1−/− T-cell defect. Molecular Immunology. 45(3). 682–689. 1 indexed citations

Izon, David J., et al.. (2007). TLX1/HOX11 transcription factor inhibits differentiation and promotes a non‐haemopoietic phenotype in murine bone marrow cells. British Journal of Haematology. 138(1). 54–67. 11 indexed citations

Rice, Kim L., et al.. (2007). Overexpression of stem cell associated ALDH1A1, a target of the leukemogenic transcription factor TLX1/HOX11, inhibits lymphopoiesis and promotes myelopoiesis in murine hematopoietic progenitors. Leukemia Research. 32(6). 873–883. 29 indexed citations

Izon, David J., Jon C. Aster, Yiping He, et al.. (2002). Deltex1 Redirects Lymphoid Progenitors to the B Cell Lineage by Antagonizing Notch1. Immunity. 16(2). 231–243. 211 indexed citations

Izon, David J., Jennifer A. Punt, & Warren S. Pear. (2002). Deciphering the role of Notch signaling in lymphopoiesis. Current Opinion in Immunology. 14(2). 192–199. 49 indexed citations

Izon, David J., William DeMuth, Warren S. Pear, et al.. (2001). A Common Pathway for Dendritic Cell and Early B Cell Development. The Journal of Immunology. 167(3). 1387–1392. 95 indexed citations

10.

Taubenberger, Jeffery K., Ann Reid, David J. Izon, & Stefen A. Boehme. (1996). Development and Characterization of v-myc/v-raf-Transformed Murine Fetal Thymocyte Cell Lines. Cellular Immunology. 171(1). 41–47. 8 indexed citations

11.

Izon, David J., et al.. (1996). Identification and functional analysis of Ly-6A/E as a thymic and bone marrow stromal antigen. The Journal of Immunology. 156(7). 2391–2399. 29 indexed citations

12.

Verbeek, Sjef, David J. Izon, Frans M.A. Hofhuis, et al.. (1995). An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature. 374(6517). 70–74. 420 indexed citations

13.

Izon, David J., Lori Jones, Elizabeth E. Eynon, & Ada M. Kruisbeek. (1994). A molecule expressed on accessory cells, activated T cells, and thymic epithelium is a marker and promoter of T cell activation.. The Journal of Immunology. 153(7). 2939–2950. 11 indexed citations

14.

Izon, David J., John D. Nieland, Lori Jones, & Ada M. Kruisbeek. (1993). T Cell Tolerance and Antigen Presenting Cell Function in the Thymus. Advances in experimental medicine and biology. 329. 159–164. 2 indexed citations

15.

Boyd, Richard L., C L Tucek, Dale I. Godfrey, et al.. (1993). The thymic microenvironment. Immunology Today. 14(9). 445–459. 383 indexed citations

16.

Jones, Lori, David J. Izon, John D. Nieland, Peter S. Linsley, & Ada M. Kruisbeek. (1993). CD28-B7 interactions are not required for intrathymic clonal deletion. International Immunology. 5(5). 503–512. 46 indexed citations

17.

Godfrey, Dale I., David J. Izon, C L Tucek, Trevor J. Wilson, & R L Boyd. (1990). The phenotypic heterogeneity of mouse thymic stromal cells.. PubMed Central. 70(1). 66–74. 86 indexed citations

18.

Izon, David J., Richard L. Boyd, Gary A. Waanders, & Anne Kelso. (1989). The myelopoietic inducing potential of mouse thymic stromal cells. Cellular Immunology. 124(2). 264–277. 9 indexed citations

19.

Boyd, Richard L., David J. Izon, Dale I. Godfrey, et al.. (1988). Complex Heterogeneity of the Thymic Stroma. Advances in experimental medicine and biology. 237. 263–268. 7 indexed citations

20.

Godfrey, Dale I., David J. Izon, Trevor J. Wilson, C L Tucek, & Richard L. Boyd. (1988). Thymic Stromal Elements Defined by M.Abs: Ontogeny, and Modulation in Vivo By Immunosuppression. Advances in experimental medicine and biology. 237. 269–275. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact